Evidence map›Paper›PMID 41139201›Full record

ArticleCarcinogenesis2025

CarD-T: an automated pipeline for the nomination and analysis of potential human carcinogens.

Jamey O'Neill, Gudur Ashrith Reddy, Nermeeta Dhillon, Osika Tripathi, Ludmil Alexandrov, Parag Katira

Abstract read
In one paragraph

Article in Carcinogenesis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jamey O'NeillMechanical Engineering Department, San Diego State University, San Diego, CA 92182, United States.ORCID 0009-0001-8532-8405
Gudur Ashrith ReddyMechanical Engineering Department, San Diego State University, San Diego, CA 92182, United States.
Nermeeta DhillonMechanical Engineering Department, San Diego State University, San Diego, CA 92182, United States.
Osika TripathiHerbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA 92093, United States.
Ludmil AlexandrovDepartment of Bioengineering, University of California San Diego, La Jolla, CA 92093, United States.ORCID 0000-0003-3596-4515
Parag KatiraMechanical Engineering Department, San Diego State University, San Diego, CA 92182, United States.ORCID 0000-0001-9873-5117

Funding

The Research Infrastructure Core of SDSU HealthLINK Center for Transdisciplinary Health Disparities ResearchU54MD012397 · NIMHD · SAN DIEGO STATE UNIVERSITY · PI MIGUEL T VILLODAS · 2018 to 2026
$39.0M
Building Capacity and Infrastructure for Population Health and Health Disparities Research at San Diego State UniversityS21MD010690 · NIMHD · SAN DIEGO STATE UNIVERSITY · PI AYALA, GUADALUPE X, CASTILLO, JOSE E · 2016 to 2020
$10.0M
TALENT Shared Resources CoreU54CA285115 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MARIA ELENA MARTINEZ · 2023 to 2026
$6.6M
Research Education CoreU54CA285117 · NCI · SAN DIEGO STATE UNIVERSITY · PI Shiloh A Williams · 2023 to 2026
$6.2M
NCI NIH HHS U54 CA285115NCI NIH HHS U54 CA285117NCI NIH HHS U54CA285117NIHNIMHD NIH HHS S21 MD010690NIMHD NIH HHS U54 MD012397NIMHD NIH HHS U54MD012397
6 · The paper itself

Abstract

The identification and classification of carcinogens is critical in cancer epidemiology, necessitating updated methodologies to manage the burgeoning biomedical literature. We introduce the Carcinogen Detection via Transformers (CarD-T) framework, combining transformer-based machine learning with probabilistic analysis to efficiently nominate potential carcinogens from scientific texts. Trained on 60% of established carcinogens, CarD-T correctly identifies all remaining known carcinogens and nominates ∼1600 potential new carcinogens. Comparative assessment against GPT-4 reveals CarD-T's comparable precision (0.896 versus 0.903), and superior recall (0.853 versus 0.757), implying an improved ability to nominate potential carcinogens for further evaluation. CarD-T associates each nominated entity with relevant scientific literature, allowing for additional analysis of conflicting implications over time through a Bayesian probabilistic carcinogen denomination analysis. The framework also provides rich insights into carcinogenesis associated research, revealing significant shifts in research focus on carcinogenic agents over time, from chemical carcinogens to broader categories including biological agents, environmental factors and lifestyle choices. We establish the CarD-T framework as a locally deployable, computationally inexpensive, and robust tool for identifying and nominating potential carcinogens from vast biomedical literature. This framework enhances the agility of public health responses to carcinogen identification, setting a new benchmark for automated, scalable toxicological investigations.

Indexed as

CarcinogensMachine LearningNeoplasmsBayes TheoremCarcinogenesisHumansCarcinogensautomated literature reviewbiomedical language modelscancer epidemiologycarcinogen literature reviewpublic healthtemporal research modelingtoxicology

Identifiers

PMID41139201
PMCPMC12780885

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.